Outcome of first salvage therapy for multiple myeloma (MM) in real-world clinical practice: Results from the third interim analysis of the multinational, observational, non-interventional EMMOS study

There is a lack of objective data on country-to-country variation in treatment practices and outcomes for MM. The EMMOS study was designed to capture real-world data on treatments for MM at different stages of the disease. Here we report results from the third interim analysis, focusing on outcomes with prospective first salvage therapy in patients (pts) who had undergone stem cell transplantation (SCT) in any treatment line at the time of data extraction (29 Dec 2014).